EUVIMEDEUVIMED entdecken
Open Access

Glycoprotein VI is a receptor for the PF4/anti-PF4 IgG complex and contributes to platelet activation in heparin-induced thrombocytopenia (HIT)

Ivo M B Francischetti, Kathryn E Dane, Ed L Galgo, Michael B Streiff, John F Andersen

Journal of Thrombosis and Haemostasis · 2025-11 · 23 (11) · 3640-3647

DOI: 10.1016/j.jtha.2025.07.016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2025-11. Verfasst von Ivo M B Francischetti und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Electronic address: ifranci3@jh.edu. Hauptthemen laut MEDLINE: Platelet Factor 4, Thrombocytopenia, Heparin, Receptors, IgG. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS, School of Medicine, Johns Hopkins University, Johns Hopkins University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Platelet factor 4 (PF4) plays a central role in heparin-induced thrombocytopenia (HIT). PF4 is a positively charged tetramer that forms immune complexes with anti-PF4 immunoglobulin G, activating platelets via FcγRIIA. Despite extensive study, a platelet receptor for PF4 within these complexes has not been clearly defined. OBJECTIVE: We hypothesized that glycoprotein VI (GPVI), a collagen receptor known to interact with multiple ligands, binds PF4 and contributes to platelet activation in HIT. METHODS: We used platelet aggregation assays, surface plasmon resonance, and AlphaFold 3 modeling to investigate interactions between PF4, the HIT-mimicking monoclonal antibody KKO, and GPVI. RESULTS: Platelet aggregation triggered by PF4/KKO or HIT patient sera was reduced by anti-GPVI antibodies or the anti-GPVI Fab fragment ACT017. Surface plasmon resonance showed that PF4 binds GPVI with a dissociation constant of Kd approximately equal to 1 μM, but PF4/KKO complexes exhibited enhanced binding, with a 5 to 17-fold reduction in dissociation rate and Kd approximately equal to 30 to 100 nM. This interaction was blocked by heparin. In contrast, the nonpathogenic anti-PF4 antibody RTO had no effect. AlphaFold 3 modeling predicted electrostatic interactions between anionic GPVI surfaces and the PF4/KKO complex, with PF4 tetramers contacting both the GPVI D2 domain and KKO Fab. CONCLUSION: GPVI functions as a receptor for PF4/HIT antibody complex, engaging FcγRIIA and contributing to platelet activation in HIT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Platelet Factor 4ThrombocytopeniaHeparinReceptors, IgGImmunoglobulin GAnticoagulantsPlatelet Membrane GlycoproteinsHumansSurface Plasmon ResonanceProtein BindingPlatelet AggregationAntigen-Antibody ComplexModels, MolecularBinding Sites

Stichwörter der Autor:innen

ACT017AlphaFold 3GPVIHITcollagenglenzocimabplateletsthrombosis

Substanzen

platelet membrane glycoprotein VIPlatelet Membrane GlycoproteinsPlatelet Factor 4PF4 protein, humanHeparinReceptors, IgGImmunoglobulin GFc gamma receptor IIAAntigen-Antibody ComplexAnticoagulants

Autor:innen und Institutionen

  • Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Electronic address: ifranci3@jh.edu.
  • Department of Pharmacy, The Johns Hopkins Hospital, Baltimore, Maryland, USA.
  • Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Department of Medicine, Division of Hematology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA. Electronic address: jandersen@niaid.nih.gov.

Förderung

  • Intramural NIH HHS
  • School of Medicine, Johns Hopkins University
  • Johns Hopkins University
  • National Institute of Allergy and Infectious Diseases
  • National Institutes of Health

Zitieren

APA

Francischetti, I. M. B., Dane, K. E., Galgo, E. L., Streiff, M. B., & Andersen, J. F. (2025). Glycoprotein VI is a receptor for the PF4/anti-PF4 IgG complex and contributes to platelet activation in heparin-induced thrombocytopenia (HIT). Journal of Thrombosis and Haemostasis, 23(11), 3640-3647. https://doi.org/10.1016/j.jtha.2025.07.016

Vancouver

Francischetti IMB, Dane KE, Galgo EL, Streiff MB, Andersen JF. Glycoprotein VI is a receptor for the PF4/anti-PF4 IgG complex and contributes to platelet activation in heparin-induced thrombocytopenia (HIT). Journal of Thrombosis and Haemostasis. 2025;23(11):3640-3647. doi:10.1016/j.jtha.2025.07.016

BibTeX
@article{Francischetti2025,
  author = {Francischetti, Ivo M B and Dane, Kathryn E and Galgo, Ed L and Streiff, Michael B and Andersen, John F},
  title = {Glycoprotein VI is a receptor for the PF4/anti-PF4 IgG complex and contributes to platelet activation in heparin-induced thrombocytopenia (HIT)},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2025},
  volume = {23},
  number = {11},
  pages = {3640--3647},
  doi = {10.1016/j.jtha.2025.07.016}
}
Kostenlos starten →